Cyclo Therapeutics, Inc. (CTDH: OTCQB) | Cyclo Therapeutics, Inc. Announces Maurizio Scarpa, MD as EU Coordinating Investigator for the Company’s Pivotal Trial in Niemann-Pick Disease Type C

OTC Markets Group – News, Filings & Corporate Actions

Pin It